Sleep, Inflammation, and Anxiety During Menopause: How Cannabinoids May Help Support Balance
Menopause is often described as a hormonal milestone—but for many women, the transition can bring significant changes to sleep, mood, and overall well-being. Emerging research suggests that these symptoms may be connected not only to hormone shifts but also to changes in inflammation and neurobiology.
At Blue Sky CBD, our Director of Research and Development, Dr. Eric Dorninger, ND, LAc, has spent years studying how phytocannabinoids interact with the body’s natural regulatory systems. In a recent educational lecture, he explored the growing scientific conversation around menopause, inflammation, and the potential role cannabinoids may play in supporting balance during this life stage.
Menopause and the Inflammatory Shift
Estrogen and progesterone are widely known for their role in reproduction, but they also play important roles throughout the body. These hormones help regulate immune activity, support tissue health, and influence neurotransmitters that affect mood and sleep.
As estrogen and progesterone decline during menopause, the body may experience changes in inflammatory signaling. Researchers have observed that certain inflammatory markers can increase during this transition, which may influence sleep quality, cognitive function, and emotional well-being.
This shift may help explain why many women report challenges such as:
-
Difficulty falling or staying asleep
-
Increased anxiety or mood changes
-
Brain fog or difficulty concentrating
-
Changes in stress resilience
The Endocannabinoid System: A Key Regulator
The body’s endocannabinoid system (ECS) plays a role in maintaining balance across multiple physiological processes, including sleep, mood, immune function, and stress response.
The ECS works through naturally occurring compounds called endocannabinoids, which interact with receptors throughout the brain and body. Lifestyle factors such as movement, nutrition, and social connection can influence this system—but plant-derived cannabinoids may also interact with these pathways.
CBD, CBG, and CBN: Emerging Areas of Interest
Research is continuing to explore how different cannabinoids may support overall wellness.
CBD (cannabidiol) has been studied for its interactions with receptors involved in mood regulation and inflammation balance. Many individuals incorporate CBD into their routines as part of a broader wellness approach.
CBN (cannabinol) has gained attention in sleep research and is being explored for its potential role in nighttime relaxation.
CBG (cannabigerol) is another cannabinoid currently being studied for its interaction with multiple biological pathways.
Together, these cannabinoids are part of a growing field of research focused on how plant compounds interact with the body’s natural regulatory systems.
Supporting Women Through the Menopause Transition
Menopause is a complex and highly individualized experience. Lifestyle habits—including sleep hygiene, nutrition, movement, and stress management—can all play a role in supporting well-being during this time.
Emerging research suggests cannabinoids may also be a valuable part of a comprehensive wellness approach for some individuals.
At Blue Sky CBD, we are committed to advancing research and education in this area. Under the guidance of Dr. Eric Dorninger, our team continues to explore how phytocannabinoids interact with human physiology and how high-quality cannabinoid products can support everyday wellness.
Looking Ahead
As scientific understanding of menopause continues to evolve, one thing is becoming clear: this stage of life deserves thoughtful attention, research, and support.
Through continued education and responsible product development, Blue Sky CBD aims to help individuals make informed choices about their wellness routines.
